Leaflet NASIC nasal spray, solution


Indicated for: acute rhinitis; nasal congestion

Substance: dexpanthenol + xylometazoline (wound-healing agent + adrenergic decongestant)

ATC: R01AB06 (Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, combinations excl. corticosteroids)

The combination of dexpanthenol and xylometazoline is used to relieve nasal congestion and protect irritated nasal mucosa. Xylometazoline is a decongestant that reduces swelling of blood vessels in the nose, while dexpanthenol helps regenerate and hydrate the nasal mucosa.

The medication is available as a nasal spray and is usually used 2-3 times a day for a limited period (maximum 7 days), as directed by a doctor.

Side effects may include nasal dryness, a burning sensation, or local irritation. Prolonged use may lead to rebound congestion (worsened nasal congestion).

Patients should follow the recommended dosage and avoid long-term use. Pregnant or breastfeeding women should consult a specialist before use.

General data about NASIC

  • Substance: dexpanthenol + xylometazoline
  • Date of last drug list: 01-07-2013
  • Commercial code: W43742001
  • Pharmaceutical form: nasal spray, solution
  • Packing volume: 10ml
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: KLOSTERFRAU BERLIN GMBH - GERMANIA
  • Holder: CASSELLA-MED GMBH&CO. KG - GERMANIA
  • Number: 9132/2016/01
  • Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-12 weeks